Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
Sheng Zhang, Peng Wu, Jia Liu, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 87-97
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Inflammation and aging: signaling pathways and intervention therapies
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 486
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Can Hu, Xin Zhang, Teng Teng, et al.
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 103-103
Open Access | Times Cited: 106
Role of acetylation in doxorubicin-induced cardiotoxicity
Daisong Li, Yanyan Yang, Shizhong Wang, et al.
Redox Biology (2021) Vol. 46, pp. 102089-102089
Open Access | Times Cited: 99
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Konstantinos Evangelou, Panagiotis Vasileiou, Angelos Papaspyropoulos, et al.
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 609-647
Open Access | Times Cited: 56
Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure
Milton Packer
JACC Heart Failure (2022) Vol. 11, Iss. 1, pp. 106-114
Open Access | Times Cited: 46
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23
Taxifolin Protects Against 5-Fluorouracil-Induced Cardiotoxicity in Mice Through Mitigating Oxidative Stress, Inflammation, and Apoptosis: Possible Involvement of Sirt1/Nrf2/HO-1 Signaling
Mohammad H. Abukhalil, Zina M. Al‐Alami, Manal A. Alfwuaires, et al.
Cardiovascular Toxicology (2025)
Closed Access | Times Cited: 1
Isoliquiritigenin prevents Doxorubicin-induced hepatic damage in rats by upregulating and activating SIRT1
Wahidah H. Al-Qahtani, Ghedeir M. Alshammari, Jamaan S. Ajarem, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112594-112594
Open Access | Times Cited: 44
Therapeutic opportunities for senolysis in cardiovascular disease
Mark Sweeney, Stuart A. Cook, Jesús Gil
FEBS Journal (2022) Vol. 290, Iss. 5, pp. 1235-1255
Open Access | Times Cited: 33
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling
Youheng Wang, Rusheng Zhao, Chengyan Wu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
The potential beneficial role of Ginkgetin in doxorubicin-induced hepatotoxicity: Elucidating the underlying claim
Fatemah A. Alherz, Walaa A. Negm, Thanaa A. El‐Masry, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115010-115010
Open Access | Times Cited: 13
Phloretin alleviates doxorubicin-induced cardiotoxicity through regulating Hif3a transcription via targeting transcription factor Fos
Xiangyun Li, Taoli Sun, Jiaqin Liu, et al.
Phytomedicine (2023) Vol. 120, pp. 155046-155046
Closed Access | Times Cited: 12
NADPH Oxidases in Cancer Therapy-Induced Cardiotoxicity: Mechanisms and Therapeutic Approaches
Ayat Hussein Adhab, Farag M. A. Altalbawy, Morug Salih Mahdi, et al.
Cardiovascular Toxicology (2025)
Closed Access
Mitigating seizure-induced cognitive deficits in mice induced with pentylenetetrazol by roflumilast through targeting the NLRP3 inflammasome/BDNF/SIRT3 pathway and regulating ferroptosis
Mohamed N Fawzy, Enas A. Abd El‐Haleim, Hala F. Zaki, et al.
Life Sciences (2025), pp. 123488-123488
Closed Access
Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies
Yingpu Sun, Lili Xiao, Linlin Chen, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Cariporide Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Inhibiting Oxidative Stress, Inflammation and Apoptosis Partly Through Regulation of Akt/GSK-3β and Sirt1 Signaling Pathway
Wenli Liao, Zhiwei Rao, Lingling Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats
Adel A. Gomaa, Hanan S.M. Farghaly, Asmaa M. Ahmed, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109927-109927
Closed Access | Times Cited: 9
Roflumilast reduces myocardial ischemia reperfusion injury in vivo and in vitro by activating the AMPK signaling pathway
Bo Liao, Han Zhongyuan
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 5
4-Deoxy-ε-Pyrromycinone: A Promising Drug/Lead Compound to Treat Tumors
J. Zhang, Xianan Sang, Yichao Yuan, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2367-2379
Open Access | Times Cited: 1
Protective effects and mechanisms of lycorine against adriamycin-induced cardiotoxicity
Zheng Wang, Ying Chen, Mingming Gu, et al.
Phytomedicine (2022) Vol. 102, pp. 154178-154178
Closed Access | Times Cited: 7
SGK1 is involved in doxorubicin-induced chronic cardiotoxicity and dysfunction through activation of the NFκB pathway
Yu Zhang, Dan Zhang, Tingting Meng, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111151-111151
Closed Access | Times Cited: 3
Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity
Tianhu Wang, Yan Ma, Shan Gao, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 11, pp. 336-336
Open Access | Times Cited: 3
Molecular mechanisms mediate roflumilast protective effect against isoprenaline-induced myocardial injury
Marwa M. M. Refaie, Manar Fouli Gaber Ibrahim, Michael Atef Fawzy, et al.
Immunopharmacology and Immunotoxicology (2023) Vol. 45, Iss. 6, pp. 650-662
Closed Access | Times Cited: 2
Sanggenol L alleviates Rotenone-induced Parkinson’s disease inhibits mitochondrial complex I by apoptotic via P13K/AKT/mTOR signalling
Nan Zhao, Menghai Wu, Jianbin Zhang
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top